Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 2,449 | 2,529 | 3,090 | 3,181 | 3,704 |
| Operating Income | -2,449 | -2,529 | -3,090 | -3,181 | -3,704 |
| Other Income | 134 | 1,591 | -272 | 2,799 | -1,056 |
| Pre-tax Income | -2,315 | -938 | -3,362 | -382 | -4,760 |
| Income Tax | N/A | N/A | N/A | -1,018 | -605 |
| Net Income Continuous | -2,315 | -938 | -3,362 | 636 | -4,155 |
| Net Income | $-2,315 | $-938 | $-3,362 | $636 | $-4,155 |
| EPS Basic Total Ops | -0.14 | -0.06 | -0.21 | 0.11 | -0.36 |
| EPS Basic Continuous Ops | -0.14 | -0.06 | -0.21 | 0.11 | -0.36 |
| EPS Diluted Total Ops | -0.14 | -0.06 | -0.21 | 0.11 | -0.36 |
| EPS Diluted Continuous Ops | -0.14 | -0.06 | -0.21 | 0.11 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.15 | -0.21 | -0.21 | -0.26 |
| EBITDA(a) | $-2,446 | $-2,529 | $-3,088 | $-3,179 | $-3,702 |